Skip to main content

Table 1 Number of people in the study with each immune-mediated disease, and percentage who were female

From: Risk of subarachnoid haemorrhage in people admitted to hospital with selected immune-mediated diseases: record-linkage studies

Immune-mediated diseases (ICD-10 codes) England, 1999 – 2011
N % of females
Addison’s disease (E27) 11 839 59
Ankylosing spondylitis (M45) 29 136 30
Autoimmune haemolytic anaemia (D59.1) 9 241 54
Chronic active hepatitis (K73.2) 4 439 70
Coeliac disease (K90) 70 715 67
Crohn’s disease (K50) 125 240 56
Dermatomyositis (M33.0-M33.1) 2 768 67
Diabetes mellitus (E10) 426 471 46
Goodpasture’s syndrome (M31) 1 058 49
Hashimoto’s thyroiditis (E06.3) 8 630 90
Idiopathic thrombocytopenia purpura (D69) 31 043 55
Multiple sclerosis (G35) 82 256 69
Myasthenia gravis (G70) 11 279 49
Myxoedema (E03.8–E03.9) 938 696 81
Pemphigoid (L12) 13 642 56
Pemphigus (L10) 2 348 56
Pernicious anaemia (D51.0) 67 890 68
Polyarteritis nodosa (M30.0) 2 249 44
Polymyositis (M33.2) 3 860 62
Primary biliary cirrhosis (K74) 11 146 84
Psoriasis (L40) 119 454 48
Rheumatoid arthritis (M05–M06) 331 393 71
Scleroderma (M34) 11 494 82
Sjogren’s syndrome (M35.0) 17 741 89
Systemic lupus erythematosus (M32) 25 576 86
Thyrotoxicosis (E05) 132 826 79
Ulcerative colitis (K51) 180 397 49